| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004983909 |
| P356 | DOI | 10.1038/BMT.2010.9 |
| P698 | PubMed publication ID | 20154736 |
| P5875 | ResearchGate publication ID | 41429131 |
| P50 | author | Carolyn Hurley | Q89858053 |
| P2093 | author name string | A Green | |
| Donor Registries Working Group of the World Marrow Donor Association (WMDA) | |||
| E Marry | |||
| L M Foeken | |||
| M Oudshoorn | |||
| T Wiegand | |||
| P2860 | cites work | A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA). | Q49286943 |
| Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. | Q51961297 | ||
| Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy | Q56777948 | ||
| Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age | Q59647415 | ||
| Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially? | Q83919505 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 811-818 | |
| P577 | publication date | 2010-02-15 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. | |
| P478 | volume | 45 |
| Q37938486 | Algorithm for donor selection in 2011. |
| Q44033488 | Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems |
| Q50526030 | Apheresis product identification in the transplant center: development of point-of-care protocols for extended blood typing of stem cell apheresis products. |
| Q38000901 | Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision |
| Q83979724 | Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors |
| Q92867653 | Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0. |
| Q38173213 | Concise review: stem cell-based approaches to red blood cell production for transfusion |
| Q33455005 | Cord Blood Banking and Transplantation in China: A Ten Years Experience of a Single Public Bank |
| Q83964109 | Cord blood banking and transplantation in 2010 |
| Q36163071 | Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells. |
| Q33819995 | Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations. |
| Q36728745 | Donor registries and search strategies |
| Q42675717 | Effect of testosterone and hypoxia on the expansion of umbilical cord blood CD34+ cells in vitro |
| Q50483964 | Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates. |
| Q28740487 | Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase |
| Q37995979 | Ex vivo expansion of umbilical cord blood: where are we? |
| Q41976345 | Expansion of human cord blood hematopoietic stem cells for transplantation |
| Q38366631 | G-CSF-primed BM for allogeneic SCT: revisited |
| Q36055055 | HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research |
| Q85486402 | Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies |
| Q28088687 | Hematopoetic stem cell transplantation in children |
| Q35288778 | Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. |
| Q30616418 | Hematopoietic SCT in Europe: data and trends in 2011. |
| Q33733022 | Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation |
| Q36974379 | Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. |
| Q37996797 | Human umbilical cord is a unique and safe source of various types of stem cells suitable for treatment of hematological diseases and for regenerative medicine |
| Q37596625 | Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation |
| Q59938773 | Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report |
| Q41747328 | Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies |
| Q34290624 | MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation |
| Q27007110 | Manufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concerns |
| Q36666821 | Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation |
| Q38992833 | Matched unrelated donor transplants-State of the art in the 21st century |
| Q89752941 | Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies |
| Q47564628 | Next Generation Sequencing Characterizes the Extent of HLA Diversity in an Argentinian Registry Population. |
| Q92589084 | Next generation sequencing characterizes HLA diversity in a registry population from the Netherlands |
| Q58605800 | Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients |
| Q86802957 | Quality of harvest and role of cell dose in unrelated bone marrow transplantation: an Italian Bone Marrow Donor Registry-Gruppo Italiano Trapianto di Midollo Osseo Study |
| Q37788404 | Regulatory issues in cord blood banking and transplantation |
| Q89777916 | Related haploidentical donors are a better choice than matched unrelated donors: Point |
| Q85156474 | Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association |
| Q57066067 | Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges |
| Q50506365 | Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study. |
| Q33916233 | Support of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donors |
| Q35998343 | The Austrian Bone Marrow Donor Registry: Providing Patients in Austria with Unrelated Donors for Transplant - a Worldwide Cooperation |
| Q45248234 | Trends and challenges in searching for HLA-matched unrelated donors in Israel |
| Q33800639 | Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy |
| Q53091868 | Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee. |
| Q33786536 | Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. |
Search more.